APA

Schoumacher M., Hurov K. E., Lehár J., Yan-Neale Y., Mishina Y., Sonkin D., Korn J. M., Flemming D., Jones M. D., Antonakos B., Cooke V. G., Steiger J., Ledell J., Stump M. D., Sellers W. R., Danial N. N. & Shao W. (20140808). Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling. : Cancer research.

Chicago

Schoumacher Marie, Hurov Kristen E, Lehár Joseph, Yan-Neale Yan, Mishina Yuji, Sonkin Dmitriy, Korn Joshua M, Flemming Daisy, Jones Michael D, Antonakos Brandon, Cooke Vesselina G, Steiger Janine, Ledell Jebediah, Stump Mark D, Sellers William R, Danial Nika N and Shao Wenlin. 20140808. Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling. : Cancer research.

Harvard

Schoumacher M., Hurov K. E., Lehár J., Yan-Neale Y., Mishina Y., Sonkin D., Korn J. M., Flemming D., Jones M. D., Antonakos B., Cooke V. G., Steiger J., Ledell J., Stump M. D., Sellers W. R., Danial N. N. and Shao W. (20140808). Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling. : Cancer research.

MLA

Schoumacher Marie, Hurov Kristen E, Lehár Joseph, Yan-Neale Yan, Mishina Yuji, Sonkin Dmitriy, Korn Joshua M, Flemming Daisy, Jones Michael D, Antonakos Brandon, Cooke Vesselina G, Steiger Janine, Ledell Jebediah, Stump Mark D, Sellers William R, Danial Nika N and Shao Wenlin. Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling. : Cancer research. 20140808.